시장보고서
상품코드
1192973

은 함유 창상 피복재 시장 : 제품 유형별, 치료법별, 최종 사용자별 - 세계 기회 분석 및 산업 예측(2021-2031년)

Silver Wound Dressings Market By Product Type, By Treatment, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 239 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

은 함유 창상 피복재의 세계 시장은 2021년에 8억 8910만 달러로 평가되고, 2031년에는 15억 1180만 달러에 이를 전망으로 2022년부터 2031년까지의 CAGR 5.4%를 기록하면 예상되는 은 함유 창상 피복재는 항균성 피복재로 은과 일체화된 것입니다.

은은 이온화된 상태에서 항진균성이나 항균성을 높여 병원성 세균에 의한 바이오필름의 형성을 막기 위해 창상 피복재에 사용되고 있습니다. 또한, 이러한 드레싱 재료는 낮은 삼투압에서 높은 삼투압의 상처, 궤양 및 화상에 항균 작용을 발휘합니다.

시장 성장을 촉진하는 주요 요인은 스포츠 관련 상해와 교통 사고, 노인 인구 증가, 수술 급증 등 유병률 증가입니다. 예를 들어 국제 당뇨병 연맹에 따르면 2021년에는 약 5억 3,700만 명의 성인(20-79세)이 당뇨병과 공존하고 있습니다. 당뇨병 환자의 총 수는 2030년에는 6억 4,300만 명, 2045년에는 7억 8,300만 명으로 증가할 것으로 예측됩니다. 또한 120만명 이상의 소아 및 청년(0-19세)이 1형 당뇨병과 공존하고, 5억 4,100만명의 성인이 2형 당뇨병을 발병할 위험이 높아지고 있다고 추정되었습니다.

또한, 항균성, 치유 시간 단축, 감염 위험의 저하 등, 은을 포함한 드레싱의 유익한 특성에 대한 인식이 높아지고 있는 것이 시장의 성장을 뒷받침하는 주요 요인이 되고 있습니다.

그러나 은을 이용한 상처 치료 비용이 높다는 것은 시장 성장을 방해할 것으로 예상됩니다. 반면 노인 인구 증가, 상처 치료에 대한 의식 증가, 신흥 경제 국가의 고성장 옵션은 예측 기간 동안 시장 성장을위한 유리한 기회를 제공 할 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 기회
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 영향 분석

제4장 은 함유 창상 피복재 시장 : 제품 유형별

  • 개요
    • 시장 규모 및 예측
  • 시트
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 겔 크림
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
    • 겔과 크림의 은창상 피복재 시장 : 유형별
  • 발포체
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제5장 은 함유 창상 피복재 시장 : 치료법별

  • 개요
    • 시장 규모 및 예측
  • 외과적 상처
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 열상
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 궤양
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 열상과 절상
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 스킹 래프트
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제6장 은 함유 창상 피복재 시장 : 최종 사용자별

  • 개요
    • 시장 규모·예측
  • 병원과 클리닉
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 외래 수술 센터
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 재택 의료
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제7장 은 함유 창상 피복재 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미 시장 규모·예측 : 제품 유형별
    • 북미 시장 규모·예측 : 치료법별
    • 북미 시장 규모·예측 : 최종 사용자별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽 시장 규모·예측 : 제품 유형별
    • 유럽 시장 규모·예측 : 치료법별
    • 유럽 시장 규모·예측 : 최종 사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 제품 유형별
    • 아시아태평양의 시장 규모·예측 : 치료법별
    • 아시아태평양의 시장 규모·예측 : 최종 사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 일본
      • 중국
      • 호주
      • 인도
      • 한국
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 제품 유형별
    • LAMEA의 시장 규모·예측 : 치료법별
    • LAMEA의 시장 규모·예측 : 엔드유저별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 사우디아라비아
      • 남아프리카 공화국
      • 기타 LAMEA

제8장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경합의 히트 맵
  • 주요 발전

제9장 기업 프로필

  • 3M Company
  • Argentum Medical LLC
  • B Braun Melsungen AG
  • Convatec, Inc.
  • Ferris Mfg.Corp
  • Johnson And Johnson
  • Monlycke Health Care
  • Molnlycke Health Care
  • medline industries, inc.
  • DermaRite Industries, LLC.
ksm 23.03.27

The global silver wound dressings market was valued at $889.1 million in 2021, and is projected to reach $1,511.8 million by 2031, registering a CAGR of 5.4% from 2022 to 2031.Silver wound dressings are antimicrobial dressings, which are integrated with silver. The metal, in ionized form, exhibits enhanced antifungal and antimicrobial properties, and are used in wound dressings for preventing biofilm formation by pathogenic bacteria These dressings are wound care products intended to manage bioburden in acute and chronic wounds. In addition, these dressings provide antimicrobial action on low to high exudates wounds, ulcers, and burns.

The key factors that drive the growth of the market are increase in prevalence of sport related injuries and & road accidents, rise in geriatric population, and surge in number of surgical procedures. For instance, according to International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Furthermore, it was estimated that more than 1.2 million children and adolescents (0-19 years) are living with type 1 diabetes and 541 million adults are at increased risk of developing type 2 diabetes.

Moreover, the rise in awareness of the beneficial properties of silver incorporated dressing such as antimicrobial nature, reduction in healing time and lowered infection risks are the key factors boost the growth of the market.

However, the high cost of silver wound care is expected to hinder the growth of the market. On the other hand, rise in geriatric population, increasing awareness towards advanced wound care therapies and high growth optional in developing economies are anticipated to provide lucrative opportunities for the growth of the market during the forecast period. 

The silver wound dressings market is segmented on the basis of product type, treatment, end user, and region. By product type, it is categorized into sheets, gel & creams, foams, and others. The gels & creams segment is further classified into alginate, hydrogel, silver sulfadiazine and others. By treatment, the market is categorized into ulcers, skin grafts, lacerations & cuts, surgical wounds, burns, and others. By end user, the market is fragmented into hospital & clinics, ambulatory surgical centers, and homecare. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the silver wound dressings market share in 2021 and is anticipated to remain dominant during the forecast period. The market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of diabetes and chronic & acute wounds. Moreover, the presence of a number of key players involved in R&D activities for the development of technologically advanced products is contributing toward the market growth in this region.

Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of large geriatric population and constantly improving healthcare infrastructure. In addition, the rapidly growing population, and increase in number of surgical procedures and road accidents, is set to drive the market growth in the Asia-Pacific region.

The key players that operate in the silver wound dressings market include 3M (Acelity Inc.), Medline Industries, LP, Argentum Medical LLC, B. Braun Melsungen AG, Convatec Inc, Dermarite Industries, Inc, Ferris Mfg. Corp., Ltd., Johnson and Johnson, Molnlycke Health Care AB, and Smith and Nephew PLC.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the silver wound dressings market analysis from 2021 to 2031 to identify the prevailing silver wound dressings market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the silver wound dressings market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global silver wound dressings market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Sheets
  • Gels and Creams
    • Type
    • Alginate
    • Hydrogel
    • Silver sulfadiazine
    • Others
  • Foams
  • Others

By Treatment

  • Surgical Wounds
  • Burns
  • Ulcers
  • Lacerations and Cuts
  • Skin Grafts
  • Others

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Homecare

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • 3M Company
    • Argentum Medical LLC
    • , B Braun Melsungen AG
    • Convatec, Inc.
    • Ferris Mfg.Corp
    • Johnson And Johnson
    • Monlycke Health Care
    • Molnlycke Health Care
    • medline industries, inc.
    • DermaRite Industries, LLC.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Sheets
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Gels and Creams
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
    • 4.3.4 Gels and Creams Silver Wound Dressings Market by Type
  • 4.4 Foams
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market share analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market share analysis by country

CHAPTER 5: SILVER WOUND DRESSINGS MARKET, BY TREATMENT

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Surgical Wounds
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Burns
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country
  • 5.4 Ulcers
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market share analysis by country
  • 5.5 Lacerations and Cuts
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market share analysis by country
  • 5.6 Skin Grafts
    • 5.6.1 Key market trends, growth factors and opportunities
    • 5.6.2 Market size and forecast, by region
    • 5.6.3 Market share analysis by country
  • 5.7 Others
    • 5.7.1 Key market trends, growth factors and opportunities
    • 5.7.2 Market size and forecast, by region
    • 5.7.3 Market share analysis by country

CHAPTER 6: SILVER WOUND DRESSINGS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals and Clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 Homecare
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: SILVER WOUND DRESSINGS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product Type
    • 7.2.3 North America Market size and forecast, by Treatment
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Product Type
      • 7.2.5.1.3 Market size and forecast, by Treatment
      • 7.2.5.1.4 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Product Type
      • 7.2.5.2.3 Market size and forecast, by Treatment
      • 7.2.5.2.4 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Product Type
      • 7.2.5.3.3 Market size and forecast, by Treatment
      • 7.2.5.3.4 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product Type
    • 7.3.3 Europe Market size and forecast, by Treatment
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Product Type
      • 7.3.5.1.3 Market size and forecast, by Treatment
      • 7.3.5.1.4 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Product Type
      • 7.3.5.2.3 Market size and forecast, by Treatment
      • 7.3.5.2.4 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Product Type
      • 7.3.5.3.3 Market size and forecast, by Treatment
      • 7.3.5.3.4 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Product Type
      • 7.3.5.4.3 Market size and forecast, by Treatment
      • 7.3.5.4.4 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Product Type
      • 7.3.5.5.3 Market size and forecast, by Treatment
      • 7.3.5.5.4 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Product Type
      • 7.3.5.6.3 Market size and forecast, by Treatment
      • 7.3.5.6.4 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Treatment
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Product Type
      • 7.4.5.1.3 Market size and forecast, by Treatment
      • 7.4.5.1.4 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Product Type
      • 7.4.5.2.3 Market size and forecast, by Treatment
      • 7.4.5.2.4 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Product Type
      • 7.4.5.3.3 Market size and forecast, by Treatment
      • 7.4.5.3.4 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Product Type
      • 7.4.5.4.3 Market size and forecast, by Treatment
      • 7.4.5.4.4 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Product Type
      • 7.4.5.5.3 Market size and forecast, by Treatment
      • 7.4.5.5.4 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Product Type
      • 7.4.5.6.3 Market size and forecast, by Treatment
      • 7.4.5.6.4 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product Type
    • 7.5.3 LAMEA Market size and forecast, by Treatment
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Product Type
      • 7.5.5.1.3 Market size and forecast, by Treatment
      • 7.5.5.1.4 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Product Type
      • 7.5.5.2.3 Market size and forecast, by Treatment
      • 7.5.5.2.4 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Product Type
      • 7.5.5.3.3 Market size and forecast, by Treatment
      • 7.5.5.3.4 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Product Type
      • 7.5.5.4.3 Market size and forecast, by Treatment
      • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 3M Company
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Argentum Medical LLC
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 , B Braun Melsungen AG
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Convatec, Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Ferris Mfg.Corp
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Johnson And Johnson
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Monlycke Health Care
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Molnlycke Health Care
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 medline industries, inc.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 DermaRite Industries, LLC.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제